Search Results - Zhiqiang Xie
- Showing 1 - 4 results of 4
-
1
Order-Controllable Cylindrical Vector Vortex Beam Generation by Using Spatial Light Modulator and Cascaded Metasurfaces by Yanliang He, Huapeng Ye, Junmin Liu, Zhiqiang Xie, Xiaoke Zhang, Yuanjiang Xiang, Shuqing Chen, Ying Li, Dianyuan Fan
Published 2017-01-01Cylindrical vector vortex (CVV) beam, which possesses both helical phase front and spatially inhomogeneous polarization, is a promising structured light for its various applications ranging from optical communication to optical field manipulation and optical microscopy. However, approaches to genera...
Get full text
Article -
2
Effectively Identifying the Topological Charge and Polarization Order of Arbitrary Singular Light Beams Based on Orthogonal Polarization Separating by Yanliang He, Huapeng Ye, Junmin Liu, Zhiqiang Xie, Peipei Wang, Bo Yang, Xinxing Zhou, Yanxia Gao, Shuqing Chen, Ying Li, Dianyuan Fan
Published 2019-01-01Singular beams with spatially variant field distributions have various fantastic applications. However, one of the significant challenges that hinder the wide application of singular beams is how to effectively identify the topological charge and the polarization order of arbitrary singular beams. W...
Get full text
Article -
3
Comparison of Flood Resilience Between Low-Carbon and Traditional Communities: A Case Study of Kunming, China by Zheng Zhang, Dingjie Zhou, Ling Zhu, Zhiqiang Xie, Wei Cheng, Qijia Yang, Junxiao Wang, Zhiyong Yuan, Yifei Liu, Yufei Li, Ping Wen, Shihan Bai, Sidong Zhao
Published 2025-06-01Under China’s dual carbon strategy, low-carbon city construction is expected to help reduce urban flood risks. However, the flood resilience of low-carbon communities remains unclear, limiting effective disaster prevention. This study examines traditional and newly built low-carbon communities in Ku...
Get full text
Article -
4
Immune persistence of a single dose of 23-valent pneumococcal polysaccharide vaccine: A 6-year follow-up by Lili Huang, Xinyi Yang, Hong Li, Zhiqiang Xie, Taotao Zhu, Wangyang You, Zeng Wang, Jiebing Tan, Guangwei Feng, Qingmin Sun, Bin Wang, Xing Han, Yanxia Wang
Published 2025-12-01In a previous phase 3 clinical trial, a 23-valent pneumococcal polysaccharide vaccine (PPV23) induced robust immune responses in participants aged 2 years and older. We conducted this study to evaluate the immune persistence of a single dose of PPV23 6 years after vaccination. In this follow-up stud...
Get full text
Article